---
title: "Bayer Drug Beyonttra™ (Acoramidis) Approved In EU"
date: "2025-02-11 22:18:08"
summary: "BAYER AG :DRUG BEYONTTRA™ (ACORAMIDIS) APPROVED IN EU FOR TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS IN ADULTS WITH CARDIOMYOPATHYAPPROVAL BASED ON POSITIVE RESULTS FROM PHASE III ATTRIBUTE-CM STUDYBAYER WILL LAUNCH ACORAMIDIS IN EUROPE IN FIRST HALF OF THIS YEAR"
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

BAYER AG :

* DRUG BEYONTTRA™ (ACORAMIDIS) APPROVED IN EU FOR TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS IN ADULTS WITH CARDIOMYOPATHY
* APPROVAL BASED ON POSITIVE RESULTS FROM PHASE III ATTRIBUTE-CM STUDY
* BAYER WILL LAUNCH ACORAMIDIS IN EUROPE IN FIRST HALF OF THIS YEAR

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3P21JE:0-bayer-drug-beyonttra-acoramidis-approved-in-eu/)
